by Dietary Supplements Market size is expected to grow Usd 279.2 bn by 2030 at a CAGR of 8.4% over the forecast period 2021 – 2030.
A new study on the global Dietary Supplements market has been published by Precedence Research. It presents a wealth of information on key market dynamics, including the drivers, market trends, and challenges, as well as the structure of the global Dietary Supplements market. The study offers valuable information about the global Dietary Supplements market to illustrate how the market would grow during the forecast period 2021-2030. The report provides the value and volume of the global Dietary Supplements market for the period 2021–2030, considering 2019 as the base year and 2030 as the forecast year. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.
Key indicators of market growth, which include value chain as well as supply chain analyses, and Compound Annual Growth Rate (CAGR), are elucidated in the study in a comprehensive manner. This data can help readers interpret quantitative growth aspects of the global Dietary Supplements market during the forecast period.
Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1211
An extensive analysis on business strategies of leading market players is also featured in study on the global Dietary Supplements market. This can help readers understand principal factors to foresee growth in the global Dietary Supplements market. In this study, readers can also find specific data on the qualitative and quantitative growth avenues for the global market, which is expected to guide market players in making apt decisions in the future.
The report also delves into the competition landscape of the global Dietary Supplements market. Key players operating in the global market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global market report.
Key Players
- Bayer
- NBTY Inc
- Bionova Lifesciences
- Nu Skin Enterprises
- Carlyle Group
- Pfizer
- Arkopharma Laboratoires Pharmaceutiques
- Glanbia
- Herbalife International
- Abbott Laboratories
- GlaxoSmithKline
- Nature’s Sunshine Forms
- Amway
- Archer Daniels Midland
Key Questions Answered in Dietary Supplements Market Study
– What are the key factors influencing the Dietary Supplements market in each region?
– What will be the CAGR of the global Dietary Supplements market between 2017 and 2030?
– What is the future scope and changing trends in technologies in the global Dietary Supplements market?
– Which factors will impede the growth of the global Dietary Supplements market during the forecast period?
– Which are the leading companies in the global Dietary Supplements market?
– Which region is set to expand at the fastest CAGR during the forecast period?
– What is the volume (Units) of different Dietary Supplements across all regions during the forecast period?
– Which segment will have the highest revenue globally in 2030 and which segment will expand at the fastest CAGR during the forecast period?
Get Customization on this Research Report@ https://www.precedenceresearch.com/customization/1211
Research Methodology
A unique research methodology has been utilized by precedence research to conduct a comprehensive research on the growth of the global Dietary Supplements market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global Dietary Supplements market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of our study on the market as a primary source.
These primary and secondary sources provided exclusive information during interviews, which serves as a validation from Dietary Supplements industry leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in making precedence research estimates on the future prospects of the global market more reliable and accurate.
Segmentation
By Type
- Vitamins
- Minerals
- Fibers & Specialty Carbohydrates
- Omega Fatty Acids
- Botanicals
- Proteins & Amino Acids
- Others
By Form
- Capsules
- Tablets
- Gummies
- Soft gels
- Liquids
- Powders
- Others
By Application
- General Health
- Energy & Weight Management
- Gastrointestinal Health
- Diabetes
- Bone & Joint Health
- Immunity
- Cardiac Health
- Anti-cancer
- Others
By End User
- Geriatric
- Adults
- Children
- Infants
By Geography
- North America
-
-
- U.S.
- Canada
-
- Europe
-
-
- Germany
- France
- United Kingdom
- Rest of Europe
-
- Asia Pacific
-
-
- China
- Japan
- India
- Southeast Asia
- Rest of Asia Pacific
-
- Latin America
-
-
- Brazil
- Rest of Latin America
-
- Middle East & Africa (MEA)
-
-
- GCC
- North Africa
- South Africa
- Rest of Middle East & Africa
-
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Dietary Supplements Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
Chapter 5. COVID 19 Impact on Dietary Supplements Market
5.1. Covid-19: Dietary Supplements Industry Impact
5.2. Dietary Supplements Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Dietary Supplements Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Dietary Supplements Market Players to deal with Covid-19 Pandemic Scenario
Chapter 6. Dietary Supplements Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Rising health concerns and the changing lifestyles
6.1.1.2. Growth in the number of sports complexes and gymnasiums
6.1.2. Market Restraints
6.1.2.1. Rising demand for organic food
6.1.3. Market Opportunities
6.1.3.1. Emerging applications
Chapter 7. Global Dietary Supplements Market: Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Dietary Supplements Market Revenue by Market Players (2017 – 2020)
7.1.1.2. Dietary Supplements Market Revenue Market Share by Market Players (2017 – 2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users
Chapter 8. Global Dietary Supplements Market, By Type
8.1. Dietary Supplements Market, by Type, 2017-2030
8.1.1. Vitamins
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Minerals
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Fibers & Specialty Carbohydrates
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Omega Fatty Acids Botanicals
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Proteins & Amino Acids
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dietary Supplements Market, By Applications
9.1. Dietary Supplements Market, by Applications, 2017-2030
9.1.1. General Health
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Energy & Weight Management
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Gastrointestinal Health
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Diabetes
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Bone & Joint Health
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Immunity
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Cardiac Health
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Anti-cancer
9.1.8.1. Market Revenue and Forecast (2017-2030)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Dietary Supplements Market, By Form
10.1. Dietary Supplements Market, by Form, 2017-2030
10.1.1. Capsules
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Tablets
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Gummies
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Soft gels
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Liquids
10.1.5.1. Market Revenue and Forecast (2017-2030)
10.1.6. Powders
10.1.6.1. Market Revenue and Forecast (2017-2030)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Dietary Supplements Market, By End user
11.1. Dietary Supplements Market, by End user, 2017-2030
11.1.1. Geriatric
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Adults
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Children
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Infants
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Dietary Supplements Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue Forecast by Type(2017-2030)
12.1.2. Market Revenue Forecast by Application (2017-2030)
12.1.3. Market Revenue Forecast by Form (2017-2030)
12.1.4. Market Revenue Forecast by End user (2017-2030)
12.1.5. U.S
12.1.5.1. Market Revenue Forecast (2017-2030)
12.1.6. Canada
12.1.6.1. Market Revenue Forecast (2017-2030)
12.2. Europe
12.2.1. Market Revenue Forecast by Type (2017-2030)
12.2.2. Market Revenue Forecast by Application (2017-2030)
12.2.3. Market Revenue Forecast by Form (2017-2030)
12.2.4. Market Revenue Forecast by End user (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue Forecast (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue Forecast (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue Forecast (2017-2030)
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast (2017-2030)
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Type (2017-2030)
12.3.2. Market Revenue Forecast by Application (2017-2030)
12.3.3. Market Revenue Forecast by Form (2017-2030)
12.3.4. Market Revenue Forecast by End user (2017-2030)
12.3.5. China
12.3.5.1. Market Revenue Forecast (2017-2030)
12.3.6. India
12.3.6.1. Market Revenue Forecast (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue Forecast (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast (2017-2030)
12.4. LATAM
12.4.1. Market Revenue Forecast by Type (2017-2030)
12.4.2. Market Revenue Forecast by Application (2017-2030)
12.4.3. Market Revenue Forecast by Form (2017-2030)
12.4.4. Market Revenue Forecast by End user (2017-2030)
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast (2017-2030)
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast (2017-2030)
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Type (2017-2030)
12.5.2. Market Revenue Forecast by Application (2017-2030)
12.5.3. Market Revenue Forecast by Form (2017-2030)
12.5.4. Market Revenue Forecast by End user (2017-2030)
12.5.5. GCC
12.5.5.1. Market Revenue Forecast (2017-2030)
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast (2017-2030)
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast (2017-2030)
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast (2017-2030)
Chapter 13. Company Profiles
13.1. Bayer
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin (2017-2020)
13.1.4. Recent Developments and Strategies
13.2. NBTY Inc
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin (2017-2020)
13.2.4. Recent Developments and Strategies
13.3. Bionova Lifesciences
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin (2017-2020)
13.3.4. Recent Developments and Strategies
13.4. Nu Skin Enterprises
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin (2017-2020)
13.4.4. Recent Developments and Strategies
13.5. Carlyle Group
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin (2017-2020)
13.5.4. Recent Developments and Strategies
13.6. Pfizer
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin (2017-2020)
13.6.4. Recent Developments and Strategies
13.7. Arkopharma Laboratoires Pharmaceutiques
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin (2017-2020)
13.7.4. Recent Developments and Strategies
13.8. Glanbia
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin (2017-2020)
13.8.4. Recent Developments and Strategies
13.9. Herbalife International
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin (2017-2020)
13.9.4. Recent Developments and Strategies
13.10. Abbott Laboratories
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin (2017-2020)
13.10.4. Recent Developments and Strategies
13.11. GlaxoSmithKline
13.11.1. Company Overview, Business Information, Regional Presence
13.11.2. Product Portfolio Analysis
13.11.2.1. Product Details, Specification, Application
13.11.3. Revenue, Price, and Gross Margin (2017-2020)
13.11.4. Recent Developments and Strategies
13.12. Nature’s Sunshine Forms
13.12.1. Company Overview, Business Information, Regional Presence
13.12.2. Product Portfolio Analysis
13.12.2.1. Product Details, Specification, Application
13.12.3. Revenue, Price, and Gross Margin (2017-2020)
13.12.4. Recent Developments and Strategies
13.13. Amway
13.13.1. Company Overview, Business Information, Regional Presence
13.13.2. Product Portfolio Analysis
13.13.2.1. Product Details, Specification, Application
13.13.3. Revenue, Price, and Gross Margin (2017-2020)
13.13.4. Recent Developments and Strategies
13.14. Archer Daniels Midland
13.14.1. Company Overview, Business Information, Regional Presence
13.14.2. Product Portfolio Analysis
13.14.2.1. Product Details, Specification, Application
13.14.3. Revenue, Price, and Gross Margin (2017-2020)
13.14.4. Recent Developments and Strategies
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Get Full Access of this Research Report, Click here@ https://www.precedenceresearch.com/checkout/1211
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
